Recurrence Rate of Colorectal Adenomas Reduced With Endoscopic Submucosal Dissection However, more adverse events occurred compared with endoscopic mucosal resection Dec 11, 2023
Very Early ART Can Result in Sustained HIV Suppression in Neonates Newborns should be diagnosed "super early" and receive ART in maternity ward, experts say Dec 11, 2023
A Closer Look at the Approval of CRISPR/Cas9 Gene Therapy for Sickle Cell Disease This landmark event brings up broader considerations and implications for other diseases Dec 11, 2023
Teens' High BMI Tied to Early Chronic Kidney Disease "Enormous" risk increase seen in the highest BMI categories Dec 11, 2023
Prion Disease Rising in the U.S. Incidence of Creutzfeldt-Jakob disease increased, especially among women Dec 11, 2023
Giving Oropharyngeal Surfactant at Birth Is No Help to Preemies Increased rates of pneumothorax emerged among newborns treated prophylactically Dec 11, 2023
How Do We Hack the Problem of Health Information Hacking? Going back to using paper and the U.S. mail seems impractical Dec 11, 2023
In-Office Thermal Technology Superior for Dry Eye Treatment TearCare showed improved tear break-up time and meibomian gland secretion Dec 11, 2023
Would You Take Out a $200k Loan With No Real Returns for a Decade? The federal government must address medical school affordability Dec 11, 2023
Nurses, Resident Slashed; Deadly Tick Disease Outbreak; COVID Vax After Infection Health news and commentary from around the Web gathered by Ñý¼§Ö±²¥ staff Dec 11, 2023
ASCT Tops CAR T-Cell Therapy for Relapsed LBCL in Complete Remission Better 2-year PFS, OS, but not applicable to primary refractory disease Dec 10, 2023
Frontline Venetoclax-Ibrutinib for CLL Boosts Survival in Fit Patients Time-limited approach based on MRD response outperforms FCR, but U.S. applicability unclear Dec 10, 2023
Emicizumab Safe, Effective, in Infants With Hemophilia A More than half of children in study had no treated bleeds at follow-up of more than 100 weeks Dec 10, 2023
Add-On Inavolisib Ups PFS in PIK3CA-Mutated Breast Cancer Triplet therapy may surpass benefits of current "pretty active doublet" therapy, expert says Dec 10, 2023
Lovo-Cel 'Life-Changing, Transformative' in Sickle Cell Disease Near complete resolution of pain events in patients, including adolescents Dec 10, 2023
'You Can't Take the Pot Off the Fire': What We Heard This Week Quotable quotes heard by Ñý¼§Ö±²¥'s reporters Dec 10, 2023
Biden Wants States to Ensure Obamacare Plans Cover Enough Doctors and Hospitals Annual regulatory proposal also seeks to expand access to dental coverage in ACA marketplaces Dec 10, 2023
Bispecific Antibody Combination Active in Metastatic HR+/HER2+ Breast Cancer Two-thirds of patients progression free at 6 months with zanidatamab, palbociclib, fulvestrant Dec 10, 2023
Grappling With Our Deadliest Cancer Here are essential steps to improve lung cancer screening Dec 10, 2023
Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials Survival 75% worse compared with outcomes seen in registrational studies Dec 10, 2023
Completely Oral Regimen Effective, Feasible in APL 97% of patients alive and relapse-free at 3 years Dec 10, 2023
Less-Frequent Surveillance Mammo Feasible in Older Breast Cancer Survivors No difference for survival outcomes for annual versus around every 2 years Dec 09, 2023
AI and Breast Cancer Screening; Cancer After Treatment for Sickle Cell Also in TTHealthWatch: mail-in cervical cancer screening kits Dec 09, 2023 podcast
Yes, Conversion Therapy Efforts Still Exist in Medical Practice Leading health associations want to end this harmful approach Dec 09, 2023
The Impracticality of Treating Healthcare as a Market Commodity And an opportunity to improve how we deliver care Dec 09, 2023
Bilateral Mastectomy Not Tied to Better Survival in BRCA1-Positive Breast Cancer However, the surgery did reduce risk of contralateral breast cancer Dec 09, 2023
FDA Inspections of Foreign Drug Manufacturers Haven't Bounced Back After Pandemic Overseas inspections "well below" pre-pandemic surveillance Dec 08, 2023
Is Omitting Radiation Therapy in Low-Risk Breast Cancer a Good IDEA? Local recurrence rate of 1% at 5 years in women ages 50-69 with genomically low-risk disease Dec 08, 2023
Kidney Disease in Pregnancy Often Overlooked for Care These women had less nephrology care prior to end-stage disease onset Dec 08, 2023
ChatGPT Takes on the Neuro Boards The AI model used very confident language, even when it was wrong Dec 08, 2023
CDC Urges Clinicians to Be Aware of Potential Clade I Mpox Cases From DRC Cases of this subtype may cause more severe disease than Clade II Dec 08, 2023
Spontaneous Coronary Artery Dissections: Treatment Recommendations Still Unheeded Assessing global care quality for a condition disproportionately affecting young women Dec 08, 2023
Prenatal RSV Infection Linked to Fetal Inflammation, Poorer Growth Study may give force to recommendations for maternal RSV vaccination Dec 08, 2023
EUS-Guided Gastroenterostomy Better Option for Cancer-Related Duodenal Blockages However, technique and technology are not widespread Dec 08, 2023
Study Supports ADC as a New Option for Endocrine-Resistant Metastatic Breast Cancer Datopotamab deruxtecan was safe and boosted quality of life Dec 08, 2023
"I'm Doing Great, So When Can I Stop My Atopic Dermatitis Treatment?" Our panel of experts discuss when might be the right time to reduce therapy Dec 08, 2023 video
Maintenance Pembrolizumab-Olaparib Fails to Boost Survival in TNBC But better safety profile versus continued pembrolizumab plus chemotherapy Dec 08, 2023
MedPod Today: Rare 'Long Vax' Cases; Macchiarini's Missteps; AI Cloned Doc's Voice? Ñý¼§Ö±²¥ reporters offer further insights on these recently covered topics Dec 08, 2023 podcast
Milestone Gene Therapies for Sickle Cell Disease Greenlit by FDA Casgevy and Lyfgenia approved for one-time treatment of sickle cell disease Dec 08, 2023
